Clinicals

Our ID-Cap™ System was recently utilized in a clinical study in Boston, MA resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the use of a digital pill system (DPS) for real-time, objective measurement of ingestions among study participants. Dr. Chai’s research report was recently published in Translational Behavioral Medicine

Those who design and run clinical trials often worry about medication adherence among trial participants. Nonadherence is a significant concern in all types of clinical trials, from earlier stages of drug development (including pharmacokinetic, pharma-codynamic, dose-finding, and dose optimization studies) to late-stage pivotal trials and post-marketing studies. Medication adherence is often neglected at every phase

In partnership with our collaborators at academic medical centers in the United States, etectRx has created a simple and streamlined training program for our FDA-cleared ID-Cap System that positions patients for success with our technology and their therapy. The training has been effectively and efficiently delivered by clinical research teams as they have successfully used

COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if patients were engaged with our digital pill system when used to track and report their medication-taking in a clinical

Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study participants. Dr. Chai’s research report was recently published in the Journal of Pharmacy Technology by SAGE. View Abstract

Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a paper drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study participants. Dr. Chai’s paper was accepted for publication and recently published in peer-reviewed medical journal AIDS and Behavior. View

Formative qualitative response of MSM with substance use to digital pills for PrEP adherence

Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills

Presentation by Aimee McCrae at the Congress on Problems of Drug Dependency Smart Capsules are a Promising Tool to Improve Medication Adherence i/n Clinical Trials

Poster by Dr. Peter Chai at Society of Behavioral Medicine